FMTX Projected Dividend Yield
Forma Therapeutics Holdings Inc ( NASDAQ : FMTX )Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Co.'s pipeline consists of four product candidates, two of which it is pursuing for its development, etavopivat for the treatment of sickle cell disease (SCD), and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Co.'s main product candidate, etavopivat, is an oral, once-daily, potentially disease-modifying therapy initially being studied for the treatment of SCD. 20 YEAR PERFORMANCE RESULTS |
FMTX Dividend History Detail FMTX Dividend News FMTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |